Pay in 4 interest-free payments of $5.61 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Hi, my name is Nancy
Other information Content details Last updated on 02 Aug 2026 | 01:03 AM (IST) Manufacturer details Name: A)Tactus Nutrasciences LLP Address: A)63/6, Hari Krupa Ind
1 This capital infusion is primarily directed toward building production capacity for orforglipron, the companys highly anticipated experimental oral non-peptide glucagon-like peptide-1 (GLP-1) receptor agonist intended for the treatment of type 2 diabetes and obesity
Depression of food intake induced in healthy subjects by glucagon
A.MikkelsenM.SchrM.et al
US$ 26.38
US$ 29.59
US$ 24.48
US$ 26.90
US$ 27.51
US$ 28.84
